Introduction:

The treatment of choice for the obstructive sleep apnea-hypopnea syndrome (OSAHS) is continuous positive air pressure in the airway (CPAP), titrating the effective pressure that eliminates obstructive events through validated methods. From the beginning of the COVID 19 pandemic, it has been recommended that conventional titration should be postponed, replacing it with self-adjusting equipment. In our population, access to these devices is difficult.

Objective:

To show whether there is a difference between the CPAP pressure level calculated through a prediction formula and the pressure determined by titration under polysomnography.

Materials and Methods:

We included patients with OSAHS who underwent effective CPAP titration and compared it with the cal culated CPAP by the Miljeteig and Hoffstein formula.

Results:

We included medical records of 583 patients, (56%) men, 51 years (41-61), apnea-hypopnea index (AHI) of 51.3 (29.2 -84.4), calculated CPAP, 9.3 cm H2O vs. effective CPAP, 8 cm H2O (p < 0.0001). Comparing according to the degree of severity of the OSAHS, the average difference between calculated CPAP and effective CPAP was 0.24, 0.21, and 0.41 (non-significant differences) for mild, moderate and severe, up to an AHI < 40; in patients with an AHI ≥ 40 this difference was 1.10 (p < 0.01). We found an ac ceptable correlation between the calculated CPAP and the effective CPAP, with an intraclass correlation coefficient of 0.621, p < 0.01.

Conclusion:

We could use CPAP pressure prediction calculations to start treatment in patients with OSAHS who don’t have access to self-adjusting therapies within the context of the pandemic, until standard calibration measures can be taken.

        · text in English     · English ( pdf )